Thomas Duflot
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Biochemistry 13
- Eicosanoids and Hypertension Pharmacology 13
-
- Cardiovascular Health and Disease Prevention 5
- Co-authors
- Fabien Lamoureux (14 shared papers)Jérémy Bellien (19 shared papers)Tony Pereira (9 shared papers)Laurent Imbert (5 shared papers)Dominique Guerrot (4 shared papers)R. Varin (1 shared paper)Christophe Morisseau (6 shared papers)Christian Thuillez (3 shared papers)
- Journals
- Atherosclerosis (2 papers)The AAPS Journal (2 papers)Multiple Sclerosis and Related Disorders (1 paper)Scientific Reports (1 paper)Journal of Hypertension (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Thomas Duflot
34 papers receiving 446 citations
Peers
Comparison fields: 5 of 90
- Biochemistry 105
- Pharmacology 64
- Internal Medicine 25
- Infectious Diseases 79
- Cardiology and Cardiovascular Medicine 97
Countries citing papers authored by Thomas Duflot
This map shows the geographic impact of Thomas Duflot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Duflot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Duflot more than expected).
Fields of papers citing papers by Thomas Duflot
This network shows the impact of papers produced by Thomas Duflot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Duflot. The network helps show where Thomas Duflot may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Duflot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 71 | |
| 2 | 2021 | 66 | |
| 3 | 2020 | 38 | |
| 4 | 2014 | 31 | |
| 5 | 2015 | 26 | |
| 6 | 2018 | 20 | |
| 7 | 2017 | 20 | |
| 8 | 2019 | 18 | |
| 9 | 2016 | 17 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 15 | |
| 12 | 2018 | 12 | |
| 13 | 2019 | 11 | |
| 14 | 2018 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2019 | 6 | |
| 19 | 2021 | 6 | |
| 20 | 2022 | 5 |
About Thomas Duflot
Thomas Duflot is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine, Physiology, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 36 papers that have together received 447 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (13 papers), Hormonal Regulation and Hypertension (7 papers), Nitric Oxide and Endothelin Effects (6 papers), Cardiovascular Health and Disease Prevention (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). The work is most often cited by research in Biochemistry (105 citations), Pharmacology (64 citations), Internal Medicine (25 citations), Infectious Diseases (79 citations) and Cardiology and Cardiovascular Medicine (97 citations). Thomas Duflot has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Fabien Lamoureux, Jérémy Bellien, Tony Pereira, Laurent Imbert, Dominique Guerrot, R. Varin, Christophe Morisseau, Christian Thuillez, Patricia Compagnon and Robinson Joannidès. Their work appears in journals such as Atherosclerosis, The AAPS Journal, Multiple Sclerosis and Related Disorders, Scientific Reports and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.